Showing 15 posts of 591 posts found.

ACM Biolabs shares positive results from phase 1 SARS-CoV-2 booster vaccine trial

September 5, 2023
Research and Development ACM Biolabs, COVID-19, Immunology, SARS-CoV-2, Vaccine, clinical trial

ACM Biolabs has announced positive topline results from its phase 1 trial of ACM-001, an adjuvanted booster vaccine for SARS-CoV-2, …

The NIH’s RECOVER initiative could lead to the first official treatment for long COVID-19

August 1, 2023
Research and Development COVID-19, Infections and infestations, NIH, clinical trials, long covid

As of 31 July 2023, The National Institutes of Health (NIH) launched the first trials of its ‘Researching COVID to …


Moderna files for FDA authorisation for updated COVID-19 vaccine

June 23, 2023
Research and Development COVID-19, FDA, Immunology, Moderna, Vaccine

Biotechnology company Moderna has announced that it has completed submission of a regulatory application to the US Food and Drug …

FDA approves first oral antiviral to treat adult patients with COVID-19

May 26, 2023
Medical Communications COVID-19, FDA, Infections and infestations, paxlovid

The US Food and Drug Administration (FDA) has announced that it has approved the oral antiviral Paxlovid (nirmatrelvir tablets and …


Moderna and Pfizer COVID-19 vaccine protection declines over time

September 16, 2021
Business Services COVID-19, FDA, Moderna, Pfizer, comirnaty

Data presented by Pfizer and Moderna ahead of the FDA’s vaccine advisory committee meeting on Friday suggest that protection from …

Sanofi complete acquisition of mRNA company Translate Bio

September 15, 2021
Research and Development 2021, 3.2 billion, COVID-19, Sanofi, Translate Bio, acquisition, mrna, vaccines

French pharma giants Sanofi continues its run of acquisitions in 2021 by completing the deal for Translate Bio, a Massachusetts-based …


BioNTech seek approval for COVID-19 vaccine in children aged 5-11

September 13, 2021
Sales and Marketing COVID-19, FDA, Vaccine, children

Children between 5 and 11 years old are to be targeted by BioNTech as the company seeks approval for younger …

China rejects a second WHO probe into COVID outbreak origin

July 22, 2021
COVID-19, China

China has rejected WHO plans for a second investigation into the origin of the coronavirus pandemic, which includes the hypothesis …

Fears for pregnant women as COVID restrictions ease

July 15, 2021
COVID-19, NHS, Vaccine, maternity

The Royal College of Obstetricians and Gynaecologists (RCOG) and the Royal College of Midwives (RCM) have expressed fears over the …


Lethal triple mix of winter viruses could “push NHS to breaking point”

July 15, 2021
COVID-19, NHS, influenza

A report from the Academy of Medical Sciences has found that a lethal triple mix of COVID-19, influenza, and the …

New warning added to J&J vaccine in US

July 13, 2021
Manufacturing and Production COVID-19, FDA, J&J, JJ, US, Vaccine

The FDA has made the decision to add a warning to the fact sheet for Johnson & Johnson’s COVID-19 vaccine, …

Spanner in the works for Sputnik V as missing data reported

July 13, 2021
Manufacturing and Production COVID-19, EMA, Russia, Vaccine

Developers of Russia’s Sputnik V COVID-19 vaccine have repeatedly failed to present data to regulators, Reuters has reported. Five sources …

Children “extremely low risk” from COVID study finds

July 9, 2021
Medical Communications COVID-19, Vaccine

The overall risk of children becoming severely ill or dying from COVID-19 is extremely low, scientists from University College London, …

Summer COVID cases set to reach 2 million with 10 million isolating

July 7, 2021
Research and Development COVID-19, Lockdown, UK, Vaccine, government

Analysis from the Guardian has found that over two million people could contract COVID-19 this summer, which could therefore lead …

UVC light found to inactivate COVID virus in study

July 6, 2021
Manufacturing and Production COVID-19, clinical trials, computer simulations, skin

A new study has found that Ultraviolet C (UVC) emitting lamps are fast, effective, and safe at inactivating SARS-CoV-2, the …

Latest content